Search results
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 4 days agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...
Updates in Parkinson's, ICH, Migraine, Muscular Dystrophy
Medscape· 1 day agoProf Christoph Diener discusses his picks for updates in neurology that were published in April...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 2 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID-19 pandemic in the US, regardless of ...
Why This Biotech Just Launched — Again — After Its 166% Run
Investor's Business Daily· 4 days agoDyne studied drugs it calls DYNE-101 and DYNE-251 in patients with myotonic dystrophy type 1 and...
Gene Panel Predicts Early HER2+ Breast Cancer Prognosis
Medscape· 4 days agoPatients with early-stage HER2+ breast cancer could soon be offered less intensive treatment based...
Nvidia Rocks, Stocks Lost in the Light, Fed Minutes Takeaways, Solomon's Song
TheStreet.com· 1 day agoMarkets appeared to be less than fully prepared that 'various [Fed] participants' had at least...
Uncover the Hidden Data on This Medical Procedure in Children
Mercola· 2 days ago“They do not publish the results [or] let any independent scientist in to look at that information,” Brian Hooker, chief scientific officer for Children’s Health Defense, said. In 1962, children received just five vaccine doses.
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks via Yahoo Finance· 7 days agoIn the past six months, Lilly has risen the highest (29.1%), while Pfizer has declined the most...
Blocking a Fair WHO Pandemic Accord Endangers Humanity
Foreign Policy Magazine· 4 days agoIn Liu Cixin’s science fiction novel The Dark Forest—part of the popular Three-Body Problem series...
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly - Altimmune (NASDAQ:ALT), Amgen...
Benzinga· 7 days agoThe obesity market has garnered much interest lately, ever since Novo Nordisk NVO received FDA...